tiprankstipranks
AuMake Ltd. (AU:XEN)
ASX:XEN
Australian Market

AuMake Ltd. (XEN) AI Stock Analysis

8 Followers

Top Page

AU:XEN

AuMake Ltd.

(Sydney:XEN)

Select Model
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.01
▲(10.00% Upside)
Action:N/ADate:10/19/25
The overall score of 43 for AuMake Ltd. is primarily driven by weak financial performance, with significant concerns in profitability and cash flow despite strong revenue growth. Technical analysis and valuation scores are neutral to slightly below average due to limited data, contributing to a cautious outlook on the stock's potential.
Positive Factors
Revenue Growth
The strong revenue growth indicates a robust demand for AuMake's products, suggesting successful market penetration and potential for future expansion in the Chinese market.
Negative Factors
Negative Cash Flow
Persistent negative cash flow can strain liquidity, limiting AuMake's ability to invest in growth and meet financial obligations, posing a risk to long-term sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The strong revenue growth indicates a robust demand for AuMake's products, suggesting successful market penetration and potential for future expansion in the Chinese market.
Read all positive factors

AuMake Ltd. (XEN) vs. iShares MSCI Australia ETF (EWA)

AuMake Ltd. Business Overview & Revenue Model

Company Description
Xenitra Limited engages in the sale of various products through its online e-commerce store in Australia, Hong Kong, Mainland China, and New Zealand. It offers beverages and alcohol; food products, including dairy, fresh fruits, seafood, honey, wi...
How the Company Makes Money
AuMake generates revenue primarily through the sale of Australian products in the Chinese market. Its revenue model includes direct sales through its e-commerce platform, which allows customers to purchase products online, as well as sales made th...

AuMake Ltd. Financial Statement Overview

Summary
AuMake Ltd. shows strong revenue growth of 74.9%, but profitability is a major concern with negative margins (net profit margin at -8.8%) and poor returns (ROE at -136.7%). Balance sheet stability is moderate with a debt-to-equity ratio of 0.46, but cash flow generation remains weak despite a slight 4.7% growth in free cash flow. Overall, financial health indicates potential but significant risks in efficiency and profitability.
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue33.67M39.77M25.87M2.67M6.01M12.44M
Gross Profit-272.37K968.93K843.62K60.17K-3.61M1.78M
EBITDA-4.17M-3.39M-5.85M-2.11M-4.78M-19.71M
Net Income-3.96M-3.48M-6.28M-3.03M-6.07M-20.12M
Balance Sheet
Total Assets6.15M8.30M4.37M6.37M10.08M17.34M
Cash, Cash Equivalents and Short-Term Investments3.17M1.72M2.03M1.55M3.04M4.26M
Total Debt1.15M1.16M2.19M0.00520.24K3.06M
Total Liabilities4.53M5.64M3.80M1.26M5.98M11.98M
Stockholders Equity1.63M2.55M524.74K5.11M4.18M5.39M
Cash Flow
Free Cash Flow-1.91M-4.26M-2.84M-3.46M-5.35M-10.48M
Operating Cash Flow-1.91M-4.26M-2.66M-3.46M-4.64M-7.99M
Investing Cash Flow70.63K-38.83K-318.20K-192.52K589.87K-2.59M
Financing Cash Flow1.42M3.93M3.58M2.00M2.59M6.59M

AuMake Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
AU$47.96M-4.206.09%17.89%6.15%-32.02%
66
Neutral
AU$37.99M-1.83-8.79%20.30%2.76%1.93%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
43
Neutral
AU$11.59M-1.17-189.66%53.75%57.58%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:XEN
AuMake Ltd.
AU:ATP
Atlas Pearls Ltd
0.11
-0.03
-19.23%
AU:STP
Step One Clothing Limited
0.21
-0.62
-75.03%

AuMake Ltd. Corporate Events

AuMake Seeks ASX Quotation for 19.5 Million New Shares
Dec 22, 2025
AuMake Limited has applied to the ASX for quotation of 19.5 million new fully paid ordinary shares under its AUK ticker, in line with the exchange’s listing rules. The additional securities, issued on 22 December 2025, expand the company&#82...
AuMake Seeks ASX Quotation for 750 Million New Shares
Dec 22, 2025
AuMake Limited has applied to the ASX for quotation of 750 million new ordinary fully paid shares under its issuer code AUK, with an issue date of 22 December 2025. The substantial increase in quoted securities, issued as part of a previously anno...
Aumake Targets High-Growth China OTC Medicine Market with Landmark Regulatory Approval
Dec 17, 2025
Aumake Limited has secured a pharmaceutical wholesale license in Hong Kong, enabling the launch of up to five online OTC stores to serve China’s rapidly growing over-the-counter (OTC) medicine market. With the potential to acquire additional...
AuMake Limited Appoints New Director with No Initial Securities Interest
Dec 17, 2025
AuMake Limited has announced the appointment of Zoran Grujic as a director, effective December 17, 2025. The initial director’s interest notice reveals that Grujic currently holds no relevant interests in securities or contracts with the com...
AuMake Limited Appoints Experienced Financial Executive to Board
Dec 17, 2025
AuMake Limited has announced the appointment of Mr. Zoran Grujic as a Non-Executive Director, effective December 17, 2025. Mr. Grujic brings over 20 years of experience in leadership roles across various industries, including financial services, F...
AuMake Limited Announces Change of Address
Dec 11, 2025
AuMake Limited has announced a change of address for its registered office and principal place of business to Suite 1507, World Tower, 87-89 Liverpool St, Sydney NSW 2000. This change, authorized by the company’s board, reflects a strategic ...
AuMake Limited Announces Major Securities Issue to Bolster Financial Position
Dec 10, 2025
AuMake Limited has announced a proposed issue of 750 million unquoted options and ordinary fully paid securities, with an exercise price of $0.004 each, set to expire two years from the date of issue. This strategic move is aimed at raising capita...
$1.5 Million Capital Boost for AuMake to Drive Growth
Dec 10, 2025
AuMake Limited has successfully raised $1.5 million through a placement to institutional, professional, and sophisticated investors. This capital will be used to bolster inventory, working capital, and cover placement costs, supporting the company...
AuMake Limited Initiates Trading Halt for Capital Raising
Dec 8, 2025
AuMake Limited has requested a trading halt on its securities as it plans a significant capital raising initiative. This strategic move is expected to impact the company’s financial operations and market positioning, with the halt lasting un...
AuMake Ltd. Targets Asian Market Growth Amidst Industry Challenges
Dec 8, 2025
AuMake Ltd. has released an investor update highlighting its strategic focus on the Asian market, aiming to enhance its market positioning and operational impact. The company acknowledges various risks such as the impact of COVID-19, competition, ...
AuMake Limited Issues New Shares Under Corporations Act Compliance
Dec 5, 2025
AuMake Limited has announced the issuance of fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice under section 708A(5)(e). The company confirms compliance with relevant provisions of the Corpora...
AuMake Limited Announces Quotation of 55 Million Securities
Dec 5, 2025
AuMake Limited, listed on the Australian Securities Exchange under the code AUK, has announced the quotation of 55 million ordinary fully paid securities as of December 5, 2025. This move is part of the company’s strategic financial activiti...
AuMake Ltd. Announces Director Resignation and Share Transfer
Dec 4, 2025
AuMake Ltd. announced the resignation of Director Jiahua (Joshua) Zhou, effective November 28, 2025. Zhou’s departure involves the transfer of his interests in 117,560,672 ordinary shares held by Zhous Australia Holding Pty Ltd. This change ...
AuMake Limited Announces Director Zhao Zhang’s Departure
Dec 4, 2025
AuMake Limited has announced the cessation of Zhao Zhang as a director, effective from November 28, 2025. Zhao Zhang, who held significant interests in the company through New Continent Australia Pty Ltd, had 100 million fully paid ordinary shares...
AuMake Limited Appoints New Director
Dec 4, 2025
AuMake Limited has announced the appointment of Carl Hagon as a director, effective November 27, 2025. The initial director’s interest notice reveals that Hagon currently holds no relevant interests in securities, either as a registered hold...
Aumake Limited Announces AGM Results
Nov 28, 2025
Aumake Limited announced the results of its annual general meeting, where all resolutions were passed by poll, although Resolution 2 and Resolution 3 were withdrawn. This outcome signifies a smooth operational process for the company, potentially ...
Aumake Limited Announces Board Restructuring for Enhanced Governance
Nov 27, 2025
Aumake Limited has announced changes to its Board of Directors to enhance governance and operational focus. Executive Directors Joshua Zhou and Tracy Zhou have resigned from the Board to concentrate on their respective business units, while Carl H...
AuMake Limited Announces 2025 Annual General Meeting
Oct 29, 2025
AuMake Limited has announced its 2025 Annual General Meeting (AGM) scheduled for November 28, 2025, at its Artarmon location. Shareholders are encouraged to participate in the meeting and vote on resolutions, either in person, by proxy, or online....
Aumake Partners with Sinomach for Premium Hay Export to China
Oct 23, 2025
Aumake Limited has entered into a non-binding Cooperation Framework Agreement with Sinomach Hainan Development Co., Ltd., a subsidiary of China National Machinery Industry Corporation. This partnership marks Sinomach’s first commercial engag...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 19, 2025